Virpax Pharmaceuticals, Inc. (VRPX)
After hours:
Chart Events
Performance Outlook
| Previous Close | 1.5000 |
| Open | 1.4400 |
| Bid | 1.4700 x 1300 |
| Ask | 1.5900 x 800 |
| Day's Range | 1.4400 - 1.5755 |
| 52 Week Range | 1.1900 - 36.0000 |
| Volume | |
| Avg. Volume | 164,230 |
| Market Cap | 17.69M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.9110 |
| Earnings Date | May 18, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- American City Business Journals
Early Money: This startup wants to help small businesses crib from Airbnb and Netflix and run successful feature tests
Many of the most successful online businesses rely on experimentation to stay on top. San Francisco startup Eppo wants to help all companies run and manage such tests.
- Quartz
Airbnb is giving homeowners $100,000 to build wacky rentals
Airbnb's $10 million initiative is a response to travelers' cravings for unique destination rentals.
- Business Wire
Virpax Pharmaceuticals to Present at H.C. Wainwright Global Investment Conference
BERWYN, Pa., May 19, 2022--Virpax® Pharmaceuticals, Inc. ("Virpax") (NASDAQ: VRPX), a company specializing in product candidates for pain management, CNS disorders and anti-viral indications, today announced that it will be presenting virtually at the upcoming H.C. Wainwright event from Tuesday, May 24th starting at 7:00 a.m. ET through Friday, May 27th. Anthony P. Mack, Chairman & CEO of Virpax, will be giving the presentation. Management will also be hosting virtual one-on-one meetings on Wedn
